39803-2
inFLIXimab [Mass/volume] in Serum or Plasma
Active
Part Description
LP35095-6 inFLIXimab
Infliximab is a genetically engineered immunoglobulin 1 murine-human chimeric monoclonal antibody against tumor necrosis factor alpha (TNFα). The murine portion is the part of the antibody that binds to TNFα while the human portion preserves functional immune capacity. Infliximab is used to treat Crohn's disease and, in particular, in treating the closure of intestinal or perianal fistulas in patients with acute intestinal involvement who have been unresponsive to other treatments. TNFα is a cytokine that acts to increase the inflammatory process in CD, RA, psoriasis and spondylarthropathy. The primary mechanism of infliximab is to combine with the inactivate soluble transmembrane TNFα. However, infliximab also modulates TNFα-producing cells through complement fixation of antibody-dependent T lymphocytes and monocytes by binding them to the IgG1 fc portion of infliximab. There is also a subsequent down-regulation of other inflammation-producing cytokines and a reduction of the level of chemokines and endothelial adhesion molecules. Negative side effects of infliximab include fibrostenosing CD and sepsis. PMID: 18360638
Source: Regenstrief LOINC
Fully-Specified Name
- Component
- inFLIXimab
- Property
- MCnc
- Time
- Pt
- System
- Ser/Plas
- Scale
- Qn
- Method
Additional Names
- Long Common Name
- inFLIXimab [Mass/volume] in Serum or Plasma
- Short Name
- inFLIXimab SerPl-mCnc
- Display Name
- inFLIXimab [Mass/Vol]
- Consumer Name Alpha Get Info
- inFLIXimab, Blood
Basic Attributes
- Class
- DRUG/TOX
- Type
- Laboratory
- First Released
- Version 2.15
- Last Updated
- Version 2.73 (MIN)
- Order vs. Observation
- Both
- Common Test Rank Get Info
- 2646
Member of these Panels
LOINC | Long Common Name |
---|---|
103791-0 | Infliximab and Infliximab Ab Panel - Serum or Plasma |
Member of these Groups Get Info
LOINC Group | Group Name |
---|---|
LG16182-4 | Infliximab| |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
de-AT | German (Austria) | Synonyms: Infliximab |
de-DE | German (Germany) | Infliximab: |
el-GR | Greek (Greece) | Ινφλιξιμάμπη: Synonyms: MCnc Ινφλιξιμάμπη |
es-ES | Spanish (Spain) | Infliximab: Synonyms: Cuantitativo |
es-MX | Spanish (Mexico) | inFLIXimab: |
et-EE | Estonian (Estonia) | Infliksimaab: Synonyms: Juhuslik Kvantitatiivne Plasma Seerum Seerum või plasma |
fr-CA | French (Canada) | Infliximab: Synonyms: #REF! |
fr-FR | French (France) | Infliximab: |
fr-BE | French (Belgium) | Infliximab: |
it-IT | Italian (Italy) | Infliximab: Synonyms: Concentrazione di Massa Livelli farmacologici e tossicologia Plasma Punto nel tempo (episodio) Siero Siero o Plasma |
ko-KR | Korean (Korea, Republic Of) | Infliximab: |
nl-NL | Dutch (Netherlands) | infliximab: |
pt-BR | Portuguese (Brazil) | InfliximAc: Synonyms: Remicade; |
ru-RU | Russian (Russian Federation) | Инфликсимаб: Synonyms: Количественный Массовая концентрация Плазма Сыворотка Сыворотка или Плазма Точка во времени; |
tr-TR | Turkish (Turkey) | İnfliksimab: |
zh-CN | Chinese (China) | 英利昔单抗: Synonyms: Infliximab 单抗; |
Example Units
Unit | Source |
---|---|
mcg/mL | REGENSTRIEF |
ug/mL | Example UCUM Units |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=39803-2
LOINC Copyright
Copyright © 2025 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://